Kurt Rasmussen
Company: Delix Therapeutics
Job title: CSO
Seminars:
Live Q&A 10:50 am
day: Day One
Substance Use Disorders as a Lifecycle Play for Neuropsychiatric Drugs 9:10 am
• How can we explore additional indications for Substance Use Disorders for drugs already in development for depression, schizophrenia, anxiety, insomnia, and the neuropsychiatric symptoms of Alzheimer’s Disease? • Evaluating current approaches being developed for Stimulant (methamphetamine and cocaine) Use DisorderRead more
day: Day One